Shay Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Shay Capital’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,200	Closed	-$90K	–	567
2022 Q2	$90K	Buy	+1,200	New	+$53.3K	0.02%	349

Shay Capital's TPTX Position: Q3 2022 in Review

Shay Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 1,200 shares — an estimated $90K sold.

Shay Capital first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $90K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Shay Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Shay Capital sold 1,200 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $90K.
Shay Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Shay Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $90K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Shay Capital's 13F filing for Q3 2022, filed 14 Nov 2022.